|
|
|
|
|
|
|
|
|
Webinar: Building Scalable Non-Viral Gene-Edited Cell Therapy Processes
|
Discover practical strategies for scaling non-viral gene-edited cell therapies from early development to GMP-ready manufacturing. This webinar explores electroporation-based workflows for T, NK, and CD34+ cells, including CRISPR knock-out, knock-in, and transposon delivery. Learn how to balance editing efficiency with viability, expansion, and downstream process needs while optimizing scalable, closed-system manufacturing approaches for long-term success in cell therapy development. Click here to learn more.
|
|
|
|
|
|
Video | Charter Medical
|
Cryopreservation is a complex system where biology, materials, and logistics intersect. Learn how early design alignment prevents late-stage failures and ensures scalable therapy success.
|
|
|
|
|
|
Webinar | MilliporeSigma
|
Know the differences between designing a viral clearance study for non-enveloped viral vectors versus those for mAbs or recombinant proteins, and how to identify and remove viral contaminants.
|
|
|
|
|
|
Webinar | Lonza
|
Uncover the secrets behind successes in commercializing and producing commercial cell and gene therapies, including establishing standards of every day, manufacturing operational excellence.
|
|
|
|
|
|
Video | Cell & Gene
|
During Cell & Gene Live, “Distributed Manufacturing for CGT: Rent, Lease, or Buy in an Era of Overcapacity?,” experts Emily Moran, Founder, 3LB Consulting, LLC and Sugu Patro, Ph.D., Senior Vice President Global Process Development at Kite, a Gilead Company shared insights into how CGT companies should think about balancing outsourced and in-house manufacturing as programs mature.
|
|
|
|
|
|
Webinar | MasterControl, Inc.
|
Discover how modern life sciences manufacturers integrate digital threads and validated AI frameworks to eliminate operational silos, build supply chain resilience, and upskill the modern workforce.
|
|
|
|
|
|
Webinar | Parexel International
|
This roundtable discussion examines the tension between legacy methods and modern innovation, exploring the complexities of hybrid trial designs and the changing regulatory landscape.
|
|
|
| Connect With Cell & Gene: |
|
|
|
|
